These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37968130)

  • 1. Association of Pathologic and Volumetric Biomarker Changes With Cognitive Decline in Clinically Normal Adults.
    Hanseeuw BJ; Jacobs HIL; Schultz AP; Buckley RF; Farrell ME; Guehl NJ; Becker JA; Properzi M; Sanchez JS; Quiroz YT; Vannini P; Sepulcre J; Yang HS; Chhatwal JP; Gatchel J; Marshall GA; Amariglio R; Papp K; Rentz DM; Normandin M; Price JC; Healy BC; El Fakhri G; Sperling RA; Johnson KA
    Neurology; 2023 Dec; 101(24):e2533-e2544. PubMed ID: 37968130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Region-Specific Association of Subjective Cognitive Decline With Tauopathy Independent of Global β-Amyloid Burden.
    Buckley RF; Hanseeuw B; Schultz AP; Vannini P; Aghjayan SL; Properzi MJ; Jackson JD; Mormino EC; Rentz DM; Sperling RA; Johnson KA; Amariglio RE
    JAMA Neurol; 2017 Dec; 74(12):1455-1463. PubMed ID: 28973551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyloid and Tau Prediction of Cognitive and Functional Decline in Unimpaired Older Individuals: Longitudinal Data from the A4 and LEARN Studies.
    Sperling RA; Donohue MC; Rissman RA; Johnson KA; Rentz DM; Grill JD; Heidebrink JL; Jenkins C; Jimenez-Maggiora G; Langford O; Liu A; Raman R; Yaari R; Holdridge KC; Sims JR; Aisen PS
    J Prev Alzheimers Dis; 2024; 11(4):802-813. PubMed ID: 39044488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased Medial Temporal Tau Positron Emission Tomography Uptake in the Absence of Amyloid-β Positivity.
    Costoya-Sánchez A; Moscoso A; Silva-Rodríguez J; Pontecorvo MJ; Devous MD; Aguiar P; Schöll M; Grothe MJ;
    JAMA Neurol; 2023 Oct; 80(10):1051-1061. PubMed ID: 37578787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of cortical microstructure with amyloid-β and tau: impact on cognitive decline, neurodegeneration, and clinical progression in older adults.
    Rodriguez-Vieitez E; Montal V; Sepulcre J; Lois C; Hanseeuw B; Vilaplana E; Schultz AP; Properzi MJ; Scott MR; Amariglio R; Papp KV; Marshall GA; Fortea J; Johnson KA; Sperling RA; Vannini P
    Mol Psychiatry; 2021 Dec; 26(12):7813-7822. PubMed ID: 34588623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tau accumulation and atrophy predict amyloid independent cognitive decline in aging.
    Fonseca CS; Baker SL; Dobyns L; Janabi M; Jagust WJ; Harrison TM
    Alzheimers Dement; 2024 Apr; 20(4):2526-2537. PubMed ID: 38334195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Emerging β-Amyloid and Tau Pathology With Early Cognitive Changes in Clinically Normal Older Adults.
    Farrell ME; Papp KV; Buckley RF; Jacobs HIL; Schultz AP; Properzi MJ; Vannini P; Hanseeuw BJ; Rentz DM; Johnson KA; Sperling RA
    Neurology; 2022 Apr; 98(15):e1512-e1524. PubMed ID: 35338074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease: A Head-to-Head Comparison Against Amyloid Positron Emission Tomography and Magnetic Resonance Imaging.
    Ossenkoppele R; Smith R; Mattsson-Carlgren N; Groot C; Leuzy A; Strandberg O; Palmqvist S; Olsson T; Jögi J; Stormrud E; Cho H; Ryu YH; Choi JY; Boxer AL; Gorno-Tempini ML; Miller BL; Soleimani-Meigooni D; Iaccarino L; La Joie R; Baker S; Borroni E; Klein G; Pontecorvo MJ; Devous MD; Jagust WJ; Lyoo CH; Rabinovici GD; Hansson O
    JAMA Neurol; 2021 Aug; 78(8):961-971. PubMed ID: 34180956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal β-Amyloid Deposition and Hippocampal Volume in Preclinical Alzheimer Disease and Suspected Non-Alzheimer Disease Pathophysiology.
    Gordon BA; Blazey T; Su Y; Fagan AM; Holtzman DM; Morris JC; Benzinger TL
    JAMA Neurol; 2016 Oct; 73(10):1192-1200. PubMed ID: 27548756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma VEGFA and PGF impact longitudinal tau and cognition in preclinical Alzheimer's disease.
    Yang HS; Yau WW; Carlyle BC; Trombetta BA; Zhang C; Shirzadi Z; Schultz AP; Pruzin JJ; Fitzpatrick CD; Kirn DR; Rabin JS; Buckley RF; Hohman TJ; Rentz DM; Tanzi RE; Johnson KA; Sperling RA; Arnold SE; Chhatwal JP
    Brain; 2024 Jun; 147(6):2158-2168. PubMed ID: 38315899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactive Associations of Vascular Risk and β-Amyloid Burden With Cognitive Decline in Clinically Normal Elderly Individuals: Findings From the Harvard Aging Brain Study.
    Rabin JS; Schultz AP; Hedden T; Viswanathan A; Marshall GA; Kilpatrick E; Klein H; Buckley RF; Yang HS; Properzi M; Rao V; Kirn DR; Papp KV; Rentz DM; Johnson KA; Sperling RA; Chhatwal JP
    JAMA Neurol; 2018 Sep; 75(9):1124-1131. PubMed ID: 29799986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarker-Based Prediction of Longitudinal Tau Positron Emission Tomography in Alzheimer Disease.
    Leuzy A; Smith R; Cullen NC; Strandberg O; Vogel JW; Binette AP; Borroni E; Janelidze S; Ohlsson T; Jögi J; Ossenkoppele R; Palmqvist S; Mattsson-Carlgren N; Klein G; Stomrud E; Hansson O
    JAMA Neurol; 2022 Feb; 79(2):149-158. PubMed ID: 34928318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alzheimer Disease Signature Neurodegeneration and APOE Genotype in Mild Cognitive Impairment With Suspected Non-Alzheimer Disease Pathophysiology.
    Schreiber S; Schreiber F; Lockhart SN; Horng A; Bejanin A; Landau SM; Jagust WJ;
    JAMA Neurol; 2017 Jun; 74(6):650-659. PubMed ID: 28319241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Amyloid and Tau With Cognition in Preclinical Alzheimer Disease: A Longitudinal Study.
    Hanseeuw BJ; Betensky RA; Jacobs HIL; Schultz AP; Sepulcre J; Becker JA; Cosio DMO; Farrell M; Quiroz YT; Mormino EC; Buckley RF; Papp KV; Amariglio RA; Dewachter I; Ivanoiu A; Huijbers W; Hedden T; Marshall GA; Chhatwal JP; Rentz DM; Sperling RA; Johnson K
    JAMA Neurol; 2019 Aug; 76(8):915-924. PubMed ID: 31157827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional Tau Deposition Reflects Different Pathways of Subsequent Neurodegeneration and Memory Decline in Cognitively Normal Older Adults.
    Chen X; Toueg TN; Harrison TM; Baker SL; Jagust WJ
    Ann Neurol; 2024 Feb; 95(2):249-259. PubMed ID: 37789559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Basal Forebrain Atrophy With Cognitive Decline in Early Alzheimer Disease.
    Xia Y; Dore V; Fripp J; Bourgeat P; Laws SM; Fowler CJ; Rainey-Smith SR; Martins RN; Rowe C; Masters CL; Coulson EJ; Maruff P
    Neurology; 2024 Jul; 103(2):e209626. PubMed ID: 38885444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.
    Pontecorvo MJ; Devous MD; Navitsky M; Lu M; Salloway S; Schaerf FW; Jennings D; Arora AK; McGeehan A; Lim NC; Xiong H; Joshi AD; Siderowf A; Mintun MA;
    Brain; 2017 Mar; 140(3):748-763. PubMed ID: 28077397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneity in Suspected Non-Alzheimer Disease Pathophysiology Among Clinically Normal Older Individuals.
    Mormino EC; Papp KV; Rentz DM; Schultz AP; LaPoint M; Amariglio R; Hanseeuw B; Marshall GA; Hedden T; Johnson KA; Sperling RA
    JAMA Neurol; 2016 Oct; 73(10):1185-1191. PubMed ID: 27548655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer's disease.
    Maass A; Landau S; Baker SL; Horng A; Lockhart SN; La Joie R; Rabinovici GD; Jagust WJ;
    Neuroimage; 2017 Aug; 157():448-463. PubMed ID: 28587897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations Between Self and Study Partner Report of Cognitive Decline With Regional Tau in a Multicohort Study.
    Jadick MF; Robinson T; Farrell ME; Klinger H; Buckley RF; Marshall GA; Vannini P; Rentz DM; Johnson KA; Sperling RA; Amariglio RE
    Neurology; 2024 Jun; 102(12):e209447. PubMed ID: 38810211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.